| Tonya Gayle Wilson, LPN | |
|
3831 Cedar Ridge Dr, Norman, OK 73072-4623 | |
| (405) 912-4585 | |
| Not Available |
| Full Name | Tonya Gayle Wilson |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 3831 Cedar Ridge Dr, Norman, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104115625 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 59422 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tonya Gayle Wilson, LPN 3801 Belhaven Circle, Norman, OK 73072 Ph: () - | Tonya Gayle Wilson, LPN 3831 Cedar Ridge Dr, Norman, OK 73072-4623 Ph: (405) 912-4585 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced presentation of data from an interim analysis of CLI-107-06 (INSPIRE), a Phase I/IIa study of HIV-infected patients with low CD4 T cell counts. The patients were treated with a three-injection cycle of the Company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107).
Lightlake Therapeutics Inc., a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that results of the Company's Phase II clinical trial of its nasal spray treatment for Binge Eating Disorder were presented at the American Psychiatric Association Annual Meeting in San Francisco by Professor Hannu Alho, MD, professor of addiction medicine at the University of Helsinki and Principal Investigator for the trial.
UCSF scientists report that they were able to prompt a new period of "plasticity," or capacity for change, in the neural circuitry of the visual cortex of juvenile mice. The approach, they say, might some day be used to create new periods of plasticity in the human brain that would allow for the repair of neural circuits following injury or disease.
Cardiac muscle degeneration (cardiomyopathy) is the most common cause of severe cardiac dysfunction and life-threatening cardiac arrhythmias in children. These severe disorders often lead to consideration of heart transplant. However, their actual cause - the genetic basis - has been poorly characterized.
Three leading scientists in the field of cardiac safety in pre-clinical drug development are gathering to discuss Improved Strategies for Pre-clinical Cardiac Testing in a free webinar on June 23 at 11:00 a.m. EDT, sponsored by the Drug Safety Council.
› Verified 9 days ago
Mrs. Joanne Carol Sherman, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 900 Main St, Norman, OK 73071 Phone: 405-620-6604 | |
Amy L Wilson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3110 Healthplex Parkway, Norman, OK 73072 Phone: 405-292-2400 | |
Berta Smith, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 909 Alameda St, Norman, OK 73071 Phone: 405-360-5100 | |
Elesa Feltham, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 900 E Main St Bldg 52, Norman, OK 73071 Phone: 405-424-7711 | |
Ms. Barbara A Smith, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 909 Alameda St, Norman, OK 73071 Phone: 405-360-5100 Fax: 405-573-3962 | |
Breyona Jones, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1120 E Main St, Norman, OK 73071 Phone: 405-573-3812 |